Complete pathological remission after treatment with olaparib in a patient with PTEN-deficient sarcomatoid prostate cancer J Wang Journal of Molecular Cancer 1 (3), 2, 2018 | 5 | 2018 |
The arrow of carcinogenesis SG Grant Journal of Molecular Cancer 1 (1), 6, 2017 | 4* | 2017 |
A Medical Nutritional Supplement Improves BMI, Hemoglobin, Fatigue levels in female anemic patients C Mehndiratta Journal of Molecular Cancer 4 (3), 1, 2021 | | 2021 |
Diabetes in pregnancy and Diabetes in children B Hira Journal of Molecular Cancer 4 (3), 1, 2021 | | 2021 |
OBESITY: A THREAT TO GENERATIONS H BHARDWAJ Journal of Molecular Cancer 4 (3), 1, 2021 | | 2021 |
Impact of Social Determinants of Health (SOC) on Prevalence of Caesarean Section among women with Gestational Diabetes Mellitus (GDM) in the United States O Akinyemi Journal of Molecular Cancer 4 (3), 1, 2021 | | 2021 |
Neurological and Molecular Mechanism of Diabetic Neuropathy K Alare Journal of Molecular Cancer 4 (3), 1, 2021 | | 2021 |
The Role of Mutations in BRCA1 BRCA2 and Other Factors Involved in Homologous Recombination in Cancer Development and Treatment PARP Inhibitors and Beyond O Dasgupta Journal of Molecular Cancer 4 (2), 1, 2021 | | 2021 |
Effectiveness of second and third generation TKIs (Dasatinib, Nilotinib and Ponatinib) in Chronic Myeloid Leukemia Treatment MK Panigrahi Journal of Molecular Cancer 4 (2), 1, 2021 | | 2021 |
LncRNA as a Therapeutic Target for Angiogenesis J Wang Journal of Molecular Cancer 4 (2), 1, 2021 | | 2021 |
Discovery and pharmacological characterization of OMO-1, a potent, highly selective and orally bioavailable MET kinase inhibitor TPS Perera Journal of Molecular Cancer 4 (2), 1, 2021 | | 2021 |
Does the coronavirus spread through food RZ Arslaan Journal of Molecular Cancer 4 (1), 1, 2021 | | 2021 |
Medical Nutritional Supplement Improve Glycemic Control in Pre-Diabetics and Type 2 Diabetics: A Prospective Study in Indian Population P Srivastava Journal of Molecular Cancer 4 (1), 1, 2021 | | 2021 |
Type 2 diabetes and heart failure J Trokis Journal of Molecular Cancer 4 (1), 1, 2021 | | 2021 |
GLUCAGON LIKE PEPTIDE AGONIST AND CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES G DIEUZEIDE Journal of Molecular Cancer 4 (1), 1, 2021 | | 2021 |
Targeting mithocondrial morphodinamics D Molino Journal of Molecular Cancer 4 (1), 1, 2021 | | 2021 |
Pathologic exam of a biopsy B Mathon* J Mol Cancer 4 (4), 2021 | | 2021 |
Oncology & Radiology 2018- Cancer Awareness and Survival W Tibairira Journal of Molecular Cancer 3 (2), 1, 2020 | | 2020 |
Cancer Oncology 2018: Cerebral aneurysms mechanisms S Bu-Yiang Journal of Molecular Cancer 3 (2), 1, 2020 | | 2020 |
Oncology & Radiology 2018: Finding substance molecule to immune stop blockade that enhances the medical care for hepatocarcinoma KM Yoon Journal of Molecular Cancer 3 (2), 1, 2020 | | 2020 |